In a previous publication1) a strain of Streptomyces hygroscopicus, newly isolated from an Easter Island soil sample, was reported to inhibit Candida albicans, Microsporum gypseum and Trichophyton granulosum. The active principle was isolated and found to be a new antibiotic of unknown structure; it was named rapamycin.
In the present paper, we are describing the fermentation of rapamycin in agitated-aerated vessels, an improved process for its isolation and purification as well as its physical-chemical characteristics.
Comparison of its activity with that of other antifungal antibiotics is also reported.
Production of Rapamycin
The producing strain, Streptomyces hygroscopicus NRRL 5491, was grown and maintained on tomato paste-oatmeal agar, as previously described1) Good growth and sporulation were obtained in 7-15 days of incubation at 25°C. Spores from one Roux bottle were suspended in 50 ml of sterile distilled water to constitute the spore inoculum.
Unbaffled, 500-m1 Erlenmeyer flasks were filled with 100 ml of an inoculum medium consisting of (g/liter): soybean meal ("Special X", Archer Daniels Midland Co., Minneapolis, Minn.), 40; "Cerelose" (a pharmaceutical grade of glucose), 20; (NH4)2SO4, 3; CaCO3, 1.5; and tap water to I liter (pH 7.0). The flasks were sterilized at 121'C for 30 minutes, cooled to 25°C and inoculated with 4 ml of the spore inoculum. The inoculated flasks were incubated for 24 hours at 25°C on a gyrotory shaker at 240 rev/min, 2"-throw, to constitute the first-stage inoculum.
Unbaffled, 24-liter round bottom flasks were filled with 3.4 liters of the same medium and autoclaved at 121 °C for 30 minutes. The flasks were agitated to resuspend the solids and autoclaved for an additional period of 1 hour at 121°C, cooled to 25°C and inoculated with 78 ml (2 %) of the first-stage inoculum. The inoculated flasks were incubated for 18 hours at 25°C on a reciprocating shaker at 65 strokes per minute and 4"-throw. These flasks were used to inoculate the production stage. Table 1 . Conventional paper disc-agar diffusion assays were used to determine the antibiotic titre. A 10-ml sample of fermentation broth was centrifuged at 2,500 rev/min for 15 minutes. The supernate was discarded and the mycelial pellet suspended in 250 ml of methanol and shaken vigorously. The extract was filtered. Filter paper discs, 13 mm in diameter, were dipped in the extract and placed on filter paper to dry. Similar discs were dipped in standard solutions containing 10, 5, 2.5 and 1.25 ug rapamycin/ml. All the discs were deposited on agar plates seeded with the test strain of Candida albicans AY F-598. The inhibition zone diameters obtained for the standard solutions after overnight incubation were plotted against log concentration on semilogarithmic paper and titre of fermentation broths read from the standard curve and corrected for dilution.
Isolation of Rapamycin
The fermentation broth was adjusted to pH 4.0 with a 30 % sulfuric acid solution and filtered on a vacuum rotary filter coated with Celite. The mycelium, containing the antibiotic, was extracted twice by stirring for 1 hour with 11 volume of trichloroethane. The trichloroethane extracts were pooled and evaporated to a small volume under reduced pressure, dehydrated with anhydrous sodium sulfate and further concentrated to an oily residue. A typical 160-liter fermentation run yielded about 500 g of oily residue. The residue was extracted twice with one volume of methanol. The methanolic extracts were pooled and evaporated to dryness to yield about 50 g of oily residue containing rapamycin. The residue was dissolved in 10 v/w of a solvent mixture consisting of 15 % acetone in hexane. To this solution, 2 weights of silica gel G (Merck) per weight of oil were added and the mixture stirred gently for 50 minutes. The mixture was filtered and silica gel with adsorbed rapamycin washed onto a column with several volumes of 15 % acetone in hexane. The antibiotic was eluted with 25 % acetone in The ultraviolet spectrum (Fig. 1) shows 2max at 288, 277 and 267 nm with E1%1cm 416, 514
and 417 respectively. The infrared spectrum (Fig. 2) shows OH at 3500, a band at 1730 (possibly lactone carbonyl) and at 1700 (carbonyl), and a band between 1610 and 1630 cm-1 (C=C).
NMR spectrum (200 MHZ) of rapamycin is shown in Fig. 3 . It shows vinylic protons between 5 5'6.5, methoxyl between 6 3.1 -3.6 and vinylic at 5 1.8.
Optical rotation is [a]25D-58.2 in methanol. Rapamycin forms a yellow chromophore when dissolved in 0.1 N methanolic NaOH and heated at 60°C; this property is the basis of a colorimetric assay.
On the basis of its ultraviolet spectrum, rapamycin can be classified as a triene, but comparison with other known trienes ( Table 2) shows it to be novel compound.
Antimicrobial
Activity of Rapamycin Rapamycin inhibits yeasts and filamentous fungi.
Results reported in Table 3 using the agar-diffusion assay indicate that rapamycin would be as active against the dermatophytes as it is against Candida albicans. However, activity expressed as minimum inhibitory concentration in broth has already been shown1) to be much higher against yeast than against the dermatophytes; Table 4 ; the minimum inhibitory concentration of rapamycin is much lower than that of amphotericin B, except for Candida pseudo tropicalis.
When compared with nystatin and candicidin using the same method, rapamycin again appeared somewhat more active against clinical isolates of Candida albicans (Table 5) . Rapamycin was also found active against candidal infections in mice; the results will be reported in a subsequent publication.7) 
